Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus

被引:161
作者
Gromowski, Gregory D. [1 ]
Barrett, Alan D. T. [1 ]
机构
[1] Univ Texas, Med Branch, Inst Infect & Immun, Ctr Biodefense & Emerging Infect Dis Dep Pathol, Galveston, TX 77555 USA
关键词
dengue; flavivirus; envelope protein domain III; neutralization; monoclonal antibodies;
D O I
10.1016/j.virol.2007.05.042
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The surface of the mature dengue virus (DENV) particle consists of 90 envelope (E) protein dimers that mediate both receptor binding and fusion. The E protein ectodomain can be divided into three structural domains designated ED I, ED2, and ED3, of which ED3 contains the critical and dominant virus-specific neutralization sites. In this study the ED3 epitopes recognized by seven, murine, IgG1 DENV-2 type-specific, monoclonal antibodies (MAbs) were determined using site-directed mutagenesis of a recombinant DENV-2 ED3 (rED3) protein. A total of 41 single amino acid substitutions were introduced into the rED3 at 30 different surface accessible residues. The affinity of each MAb with the mutant rED3s was assessed by indirect ELISA and the results indicate that all seven MAbs recognize overlapping epitopes with residues K305 and P384 critical for binding. These residues are conserved among DENV-2 strains and cluster together on the upper lateral face of ED3. A linear relationship was observed between relative occupancy of ED3 on the virion by MAb and neutralization of the majority of virus infectivity (similar to 90%) for all seven MAbs. Depending on the MAb, it is predicted that between 10% and 50% relative occupancy of ED3 on the virion is necessary for virus neutralization and for all seven MAbs occupancy levels approaching saturation were required for 100% neutralization of virus infectivity. Overall, the conserved antigenic site recognized by all seven MAbs is likely to be a dominant DENV-2 type-specific, neutralization determinant. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:349 / 360
页数:12
相关论文
共 40 条
  • [1] OLIGOMERIC REARRANGEMENT OF TICK-BORNE ENCEPHALITIS-VIRUS ENVELOPE PROTEINS INDUCED BY AN ACIDIC PH
    ALLISON, SL
    SCHALICH, J
    STIASNY, K
    MANDL, CW
    KUNZ, C
    HEINZ, FX
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (02) : 695 - 700
  • [2] Mutational evidence for an internal fusion peptide in flavivirus envelope protein E
    Allison, SL
    Schalich, J
    Stiasny, K
    Mandl, CW
    Heinz, FX
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (09) : 4268 - 4275
  • [3] Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 Å resolution
    Booy, FP
    Roden, RBS
    Greenstone, HL
    Schiller, JT
    Trus, BL
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1998, 281 (01) : 95 - 106
  • [4] Branden C, 1999, INTRO PROTEIN STRUCT, P9
  • [5] FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATION
    CHAMBERS, TJ
    HAHN, CS
    GALLER, R
    RICE, CM
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, 1990, 44 : 649 - 688
  • [6] Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
    Chen, YP
    Maguire, T
    Hileman, RE
    Fromm, JR
    Esko, JD
    Linhardt, RJ
    Marks, RM
    [J]. NATURE MEDICINE, 1997, 3 (08) : 866 - 871
  • [7] Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
    Crill, WD
    Roehrig, JT
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (16) : 7769 - 7773
  • [8] MECHANISMS OF RABIES VIRUS NEUTRALIZATION
    FLAMAND, A
    RAUX, H
    GAUDIN, Y
    RUIGROK, RWH
    [J]. VIROLOGY, 1993, 194 (01) : 302 - 313
  • [9] Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO
  • [10] 2-W